Reliability and validity of a newly developed self-administrated online questionnaire assessing the quality of life for allergic rhinitis in China: The QoLAR

一项针对中国过敏性鼻炎患者生活质量评估的新型在线自填式问卷(QoLAR)的信度和效度研究

阅读:1

Abstract

BACKGROUND: There are a few effective tools in China to assess the geography, diet, and symptoms of allergic rhinitis (AR) patients. Existing generic tools need cultural adaptation better to evaluate AR's impact on quality of life. This study aimed to develop the Quality-of-Life Questionnaire for AR patients (QoLAR), adapt it to Chinese, and assess its reliability and validity. MATERIALS AND METHODS: The present study was conducted in the following five phases: 1) Phase 1, item generation based on the literature review on AR and questionnaire development; 2) Phase 2, cultural adaptation and translation forward and backward from English to Chinese and vice versa; 3) Phase 3, pretest on 61 respondents via online messaging platform WeChat and revision of the questionnaire based on input from respondents and experts; 4) Phase 4, pilot study on 169 respondents via online messaging platform WeChat; and 5) Phase 5, statistical analysis for descriptive, reliability tests using item-total correlations and Cronbach's ɑ coefficient, and validity test using item and scale content validity indices (I-CVI, S-CVI/Ave, and S-CVI/UA). RESULTS: The final version of QoLAR comprises 44 items in four domains: sociodemographic, health status and history of AR, dietary habits, and environmental exposure. The value for Cronbach's ɑ is 0.903, and all three validity indices scored 1.00. CONCLUSIONS: A specific quality-of-life questionnaire for AR, known as QoLAR, has been created with acceptable validity and reliability. It is appropriate for an online self-reported survey and could be helpful to Chinese healthcare professionals like nurses and clinicians.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。